Detection of ovomucoid- specific low-affinity IgE in infants and its relationship to eczema.
Detection of ovomucoid- specific low-affinity IgE in infants and its relationship to eczema.
复制标题
婴儿卵类粘蛋白特异性低亲和力 IgE 的检测及其与湿疹的关系。
DOI:
10.1111/pai.12702
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Fukao T.
中科院分区:
文献类型:
--
作者:
Kawamoto N;Kamemura N;Kido H;Fukao T.
BackgroundAllergen‐specific low‐affinity IgE was previously detected in cord blood by a highly sensitive densely carboxylated protein (DCP) chip, but not by ImmunoCAP. Here, we investigated the presence of low‐affinity IgE during the early life of infants and observed its relationship with eczema.MethodsWe conducted a birth cohort study, collecting sera at birth and 6 and 14 months of age (n = 110). We monitored the ovomucoid (OM)‐ and egg white (EW)‐specific IgE (sIgE) by ImmunoCAP or DCP chip and analyzed the antigen affinity of sIgE by binding inhibition assays in the presence or absence of a mild chaotropic agent, diethyl amine (DEA). The low‐ and high‐affinity OM‐sIgEs and sensitization risk factors were analyzed by a multivariate logistic analysis.ResultsThe OM‐sIgE measured by DCP chip significantly correlated with that measured by ImmunoCAP, but some samples assessed as OM‐sIgE positive by DCP chip were considered OM‐sIgE negative by ImmunoCAP. Binding inhibition analysis after DEA treatment was performed for participants judged as OM‐sIgE positive by DCP chip at 14 M. The group assessed as negative for OM‐ and EW‐sIgE by ImmunoCAP at 6 and 14 months showed a larger binding inhibition curve shift after DEA treatment than did the group assessed as positive at these times, indicating the presence of low‐affinity sIgE antibodies at 14 months. The logistic regression analysis found that persistent eczema from 6 to 14 months is a significant risk factor for developing high‐affinity, but not low‐affinity, sIgE.ConclusionsHuman infant peripheral blood contains allergen‐specific low‐affinity sIgE. Persistent eczema is related to the development of high‐affinity, but not low‐affinity, IgE.